In an effort to identify psoriasis-associated genes, we compared gene expression in normal and psoriatic skin, using differential display RT-PCR technique. Sequence analysis of a 650-bp cDNA fragment (clone 110) that was highly up-regulated in lesional skin revealed homology to a noncoding cDNA (NICE-2). By subsequent cDNA cloning, using RNA from psoriatic skin, we have identified two alternatively spliced mRNA-isoforms (0.5 and 4.4 kb), which differ in composition of their untranslated regions. By sequence comparison, we have mapped the novel gene, named S100A15, to the S100 gene cluster within the epidermal differentiation complex (chromosome 1q21). Analysis of the deduced amino acid sequence revealed a protein of 101 amino acids containing two potential EF-hand motifs with high homology to the S100A7. Northern blot hybridization and semiquantitative RT-PCR analysis confirmed the S100A15 overexpression in psoriasis, showing different levels of expression of the S100A15 mRNA isoforms. In situ hybridization of the S100A15 revealed a markedly increased staining of basal and suprabasal epidermal layers of psoriatic skin compared with healthy tissue. Our data suggest an involvement of the novel S100A15 in epidermal differentiation and inflammation and might therefore be important for the pathogenesis of psoriasis and other diseases.
2+
-binding motifs • chromosome 1q21 • epidermal differentiation soriasis is a chronic inflammatory skin disorder affecting ~2% of the Caucasian population (1) . The disease is characterized by an increased proliferation and altered differentiation of keratinocytes (2, 3) , accompanied by vascular alterations (4, 5) and epidermal infiltration of activated T lymphocytes and antigen-presenting cells (6) (7) (8) (9) . Several studies led to the hypothesis that environmental trigger factors, for example, stress and viral and streptococcal infection, might be involved in the manifestation of the disease (10) (11) (12) . The etiology of psoriasis has not been elucidated yet; however, the identification of several candidate loci emerged from linkage studies suggests a polygenic background (13) (14) (15) (16) (17) . One of these loci has recently been assigned to the human chromosomal band 1q21, where the epidermal differentiation complex (EDC) is located (18) (19) (20) . This susceptibility region consists of three gene families encoding structural proteins and thereby affecting the terminal differentiation of the human epidermis (18, (20) (21) (22) (23) . One of these families represents the group of Ca 2+ -binding S100-proteins of EF-hand type (24) (25) (26) , of which 15 members have been identified so far (24, 27, 28) . The expression and activity of S100-proteins is modulated by the increase of cytoplasmic calcium concentration (29, 30) . Although the exact biological functions of the S100-proteins remain to be determined, they have been implicated in the Ca 2+ -dependent regulation of cell cycle progression, differentiation, and chemotaxis (reviewed in ref 31) . Thus, different S100-proteins were shown to be associated with tumor development and progression and several human skin diseases as well (reviewed in ref 32, 33) .
To date, the search for molecular alterations in psoriasis has been based on molecules and genes previously isolated, such as cytokines (34, 35) , growth factors, and protooncogenes (36) (37) (38) predicted to be involved in the pathogenesis. A different experimental approach is reverse genetics studies, in which 2-D gel electrophoresis was successfully used to identify proteins that are aberrantly regulated in skin and other diseases (39, 40) . However, due to the technical drawbacks, closely related proteins can be missed and the deduced cDNA is restricted to the coding region; therefore, alternate transcripts might be not detected.
In the present study, we have identified a novel human member of the S100 family by differential display RT-PCR (DDRT-PRC) technique comparing normal and psoriatic skin. Subsequent cDNA analysis of lesional skin revealed the presence of two alternatively spliced mRNA isoforms. Northern blot, in situ hybridization, and semiquantitative RT-PRC analysis of these gene products were performed to determine size, expression level, and distribution in healthy and psoriatic tissues. Furthermore, we analyzed the organization of the genomic locus in size and structure, determining the alternatively spliced character of the different mRNAisoforms.
MATERIALS AND METHODS

Skin samples
Split-thickness specimens (0.3 mm) of lesional and nonlesional skin, which were predominantly composed of epidermis, were obtained from 10 patients with plaque-type psoriasis of the limb or trunk (41) . For control purposes, normal skin sections were donated by healthy volunteers. All biopsies were taken with the informed patient's consent and approval of the local ethical committee.
RNA isolation
The shave biopsies were snap frozen in liquid nitrogen and homogenized in TRIZOL reagent (Invitrogen, Karlsruhe, Germany) according to the manufacturer's instructions, using a dismembrator (Braun, Melsungen, Germany). RNA integrity was evaluated by gel electrophoresis in a 2% agarose gel, with subsequent ethidium bromide staining. Total RNA concentration was determined by spectrophotometry.
Differential display RT-PCR
The original protocol (42) has been modified and successfully used for identification of UVregulated genes (43) . Briefly, 1 µg of DNase treated total RNA prepared from healthy nonlesional and lesional psoriatic skin specimens (pool of 5 samples each) was reverse transcribed using 200 U Superscript II reverse transcriptase (Invitrogen), using three different Hindlll-oligo-dT anchored primers modified at their 3′-ends to A, G, or C (HindIII-T 13 N). The resulting cDNA was used as a template in a 20 µl PCR reaction containing the HindIII-T 13 N one base-anchored primer and a HindIII-arbitrary 13-mer primer 0.2 µM each, 2 U Taq polymerase, 25 µM dNTP, and 4 µCi [ 32 P]-α-dCTP. The reactions were hot-started and cycled once for 1 min at 95°C, 1 min at 41°C, and 2 min at 72°C in the first PCR cycle, followed by 29 cycles for 50 s at 94°C, 1 min at 42°C (with temperature increment of 0.1°C/cycle), and 1 min at 72°C. In the present work, differential display anchored (5′-AAGCT 13 C-3′) and HindIII-AP29 (5′-AAGCTTAGCAGCA-3′) primers were used in combination. The radiolabeled PCR-amplified cDNA products were separated on a denaturing 6% polyacrylamide sequencing gel, which was subsequently dried on Whatmann filter paper. The cDNA bands were detected by exposure a Xray film at -70°C for 12 h.
Those cDNA bands that were identified in psoriatic tissue but missing in normal skin (or vice versa) were cut out from the dried gel. Here, we report a cDNA band of 650 bp, which was restricted to psoriatic samples. The cDNA was ethanol-glycogen precipitated, and the pellet was resolved in 10 µl H 2 O. Using the same primer combination as for the display reaction, we used 4 µl of the eluted material for reamplification under the same conditions, except for performing a touch down protocol in which the annealing temperature was decreased from 50°C to 45°C during the first five cycles and then kept constant at 45°C for 34 additional cycles. Reamplified cDNA fragments were gel-purified using the gel extraction kit (Qiagen, Hilden, Germany) and cloned via the T/A cloning procedure (pCRII-TOPO, Invitrogen, Karlsruhe, Germany).
Synthesis and cloning of the S100A15 cDNAs
Total RNA (1 µg) from psoriatic skin was denaturated at 70°C for 10 min, and first-strand cDNA was synthesized in a 20 µl reaction solution containing 4 µl 5× RT buffer (Invitrogen), 25 ng/µl oligo-dT primers, 0.5 mM dNTPs, 10 mM dithiothreitol (DTT), 40 U RNasin (Promega, Mannheim, Germany), and 200 U Superscript II-Reverse Transcriptase (Invitrogen) at 42°C for 1 h and 60°C for 10 min.
For amplification of the S100A15-specific transcripts, PCR reactions were carried out in a total volume of 20 µl, containing 1 µl of the RT sample, 2 µl 10× buffer (Qiagen), 1.5 mM MgCl 2 , 0.2 mM dNTPs, DEPC-treated water, and 2 U Taq polymerase (Qiagen) and 0.1 µM of specific intron spanning primer pairs based on sequences deposited in GenBank (genomic clone RP1-128L15, acc.no.: AL591704; partial RNA hNICE, acc.no.: AJ243672): for the S100A15-long transcript (NCBP4F sense 5′-ATCTCACTCATCCTTCTACTCGTG-3′, hNICE1R antisense, 5′-GAGCTAAGAGAGAAA GAGAGCAA) and for the S100A15-short isoform (NCBP5F sense 5′-CAAGTTCCTTCTGCTCCATCTTAG-3, NCBP4R antisense 5′-GATTGTCTTTATTTCCTGAAGGCT-3′) and β-actin (sense 5′-AGAGATGGCCACGGCTGCTT-3′, antisense 5′-ATTTGCGGTGGACGATGGAG-3′). The PCR temperature profile consisted of 31 cycles at 94°C for 1 min, 56°C for 1 min, and 72°C for 1 min (+ time increment of 2 s/cycle) followed by an additional extension step at 72°C for 5 min. The PCR products were separated on a 1.5% agarose gel, extracted (QiaexII, Qiagen), and cloned into pCRII-TOPO (Invitrogen).
Northern blot analysis
Total RNA (10 µg) from healthy nonlesional and lesional psoriatic skin was electrophoresed per lane on a 2% agarose MOPS formaldehyde gel (44) and transferred onto a Hybond-N + membrane (Amersham, Braunschweig, Germany). The probes for hybridization were generated by PCR under conditions described above using primers specific for the 5′-UTR of the short S100A15 transcript (NCBP5F sense 5′-CAAGTTCCTTCTGCTCCATCTTAG-3′, NCBP4R antisense 5′-GATTGTCTTTATTTCCTGAAGGCT-3′), the 3′-UTR of the long S100A15 isoform (P6.1 sense 5′-GAAGAGTGATCTCAACTTTCCAG-3′, P6.2 antisense 5′-TGATGAATCAACCCATTTCCTGGG-3′), and the coding region of both transcripts (NCBP8F sense 5′-AAGATTGAGAGCCAAGCCTG-3′, NCBP5R antisense 5′-ATCCTCATTCTTGTCCTTTTTCTC-3′), respectively. The PCR fragments were radioactively labeled with the High Prime DNA Labeling Kit (Roche, Mannheim, Germany) and hybridized in DIG Easy hyb solution (Roche) at 37°C. The autoradiographic signals were analyzed with a phosphoimager (ImageQuant, Molecular Dynamics, Heidelberg, Germany).
Semiquantitative RT-PCR
Following total RNA isolation, first-strand cDNA was generated by reverse transcription using 1 µg of RNA per tissue sample of each patient. The PCR reaction was performed using primers for β-actin, the short and the long S100A15 isoforms (see previous section) under PCR-conditions described above. To standardize the amount of message for the short and long S100A15 isoforms to the β-actin control, the log-linear phase of the PCR amplification was determined for each set of primers. Quantification of fragments was based on two different cycles within the log-linear phase under PCR conditions described above. Amplicons were subjected to agarose gel electrophoresis (2%) and stained with ethidium bromide. The density of the amplicons was measured by integrating UV light of the stained bands, using a digital camera image analyzing system (Multianalyst, Bio-Rad Laboratories, Hercules, CA). The amount of each S100A15 isoform message is expressed as the relative signal intensity normalized by β-actin expression (relative intensity S100A15/β-actin).
Statistical analysis between individual groups (normal nonlesional and lesional psoriatic skin) was performed using Student's t test. P < 0.01 was regarded as the level of significance. Data are expressed as means ± SE.
Sequence analysis
Insert-containing plasmids were purified from transformed Escherichia coli Top10 cells (Invitrogen) using QIAprep-spin columns (Qiagen) and sequenced with insert-specific and M13-sequencing primers.
In situ hybridization
Cryosections of normal nonlesional and lesional psoriatic skin on microscopic slides were fixed in 4% paraformaldehyde/5% formaldehyde overnight at 4°C. After washing in PBS, the slides were prehybridized in DEPC-treated precoat solution containing 5× SSC, 50% deionized formamide, 5% blocking reagent (Roche), 0.02% SDS, 0.1% N-laurylsarcosin, 50 mM Tris-HCl, pH 7.4, at 45°C for 1 h. The cRNA probes were synthesized with DIG-UTP by in vitro transcription following the manufacturer's protocol (Roche). As template for the reactions, 1 µg of pCRII vector (Invitrogen) containing a 125-bp PCR fragment specific for S100A15 (NCBP5F/NCBP4R, see previous section), linearized by XhoI, and SP6 polymerase for antisense and BamHI for T7 polymerase for sense orientation were used. The labeled probes were denatured at 65°C for 10 min, added to the prehybridized sections, and incubated overnight at 40°C under a coverslip. Subsequently, the sections were stringency washed using different steps and temperatures. For detection, an alkaline phosphatase-coupled anti-DIG-antibody and NTB/BCIP (both Roche) as a substrate were used.
Bioinformatics
Potential genomic exon/intron structures were analyzed by DIGIT, FGENESH, GENESCAN, HMMgene, and NetGene2 World Wide Web server. We performed BLAST analysis to search for homologies on both the nucleotide and protein level (National Center for Biotechnology Information; ref 45) . Multiple alignments of cDNA and protein sequences were performed with Genetool software (version 1, DoupleTwist.com) and Network protein sequence analysis (Pole Bioinformatique Lyonne LYON-GERLAND, http://npsa-pbil.ibcp.fr/cgibin/npsa_automat.pl?page=/NPSA/npsa_server.html). The ExPASy nucleotide translation tool (Swiss Institute of Bioinformatics, http://www.expasy.org/tools/dna.html) was used to translate cDNA in all six ORFs, the Genetool software (version 1) for identification of recognition sites for DNA restriction enzymes. For prediction of the protein consensus pattern, profiles, structures, and potential posttranslational modification, InterPro Scan, Hits, 3D-PSSM, and PSIPred were used, available from Swiss Institute of Bioinformatics. The PromotorInspector (Genomatix) was used for prediction of transcription factor binding sites and typical promotors.
RESULTS
Identification and characterization of the novel human S100 cDNA
Identification of differently expressed genes from healthy, uninvolved and lesional psoriatic skin was performed by DDRT-PCR analysis, yielding more than 150 cDNA fragments showing distinct signal intensities in normal and psoriatic skin. Based on a subsequently performed dot blot analysis, we focused on the cDNA fragment of ~650 bp in size showing a significantly stronger intensity in lesional psoriatic skin with the DDRT-PCR gel electrophoresis (Fig. 1) . Subsequent cloning and sequence comparison assigned clone 110 (with a cDNA insert of 618 bp) to a partial mRNA sequence of 2.1 kb, described as the 3′-untranslated region (3′-UTR) of the human NICE-2 (acc.no.: AJ243672, ref 46) . By using clone 110 as a probe for Northern blot hybridization, a transcript of ~4.4 kb was detected in RNA of psoriatic skin ( Fig. 2A) . Based on this information, we screened genomic sequence libraries for an open reading frame (ORF) 5′ of the aligned position. Multiple genomic analyses predicted a particular coding region ~4 kb upstream of clone 110 consisting of two exons (clone RP1-128L15, acc.no.: AL591704). To prove if clone 110 and the ORF predicted are part of the 4.4-kb transcript detected by Northern blot hybridization, PCR-primers specific for the 3′-UTR and the putative coding region were designed and used for cDNA amplification of psoriatic skin. As assumed, the cDNA clones obtained completed the 3′-UTR (clone 110/NICE-2) consisted of a 5′-UTR and the coding region resulting in a total transcript of 4.351 kb in size (Fig. 3A, S100A15 -L, acc.no.: AY189118). Further confirmation resulted from subsequent Northern blot analysis of psoriatic skin, using an ORF probe for hybridization (Fig. 2B) . As expected, the 4.4-kb transcript was detected, proving the connection between the coding sequence and the 3′-UTR. Unexpectedly, an additional strong band of ~500 bp appeared within the same hybridization.
Sequence analysis of the 4.4-kb transcript revealed an ORF of 306 nt (nt 58-363). The length of the isolated 5′-UTR is 57 nt containing a strong consensus sequence for initiation of translation (47) . Despite several binding sites for transcription factors, no typical promotor region was predicted 5′ of the coding region of both isoforms, using the PromoterInspector. The coding region is flanked by an 3′-UTR of 3.988 kb, spanning to the transcript previously descripted (NICE-2/clone 110). Subsequent ORF analysis predicted a sequence of 101 amino acids characteristic for a S100 protein, designated as S100A15, with a calculated molecular weight of 11,305 Da and an pI of 7.57. The deduced protein sequence of the S100A15 contains two helixloop-helix structural motifs corresponding to EF-hand Ca 2+ -binding sites, a variant S100-specific motif at the N-terminus (aa 12-39) and a canonical site at the C-terminus (aa 54-82, Fig. 4) , which are typical for S100 proteins. In addition, a bipartite nuclear targeting sequence (aa [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] and a N-myristoylation site (aa 92-97) were detected.
The predicted S100A15-protein is highly related to psoriasin (S100A7, ref 39) sharing 93% sequence identity. Comparing the functional domains, the C-terminal noncanonical EF-hand motif of the deduced S100A15 is nearly identical to that of S100A7 (28 of 29 aa), a highly conserved domain among the S100 members (Fig. 4, ref 48 ). In contrast, the N-terminus of the S100A15 presents relatively high sequence differences (3 aa mismatch) to the S100A7 within its putative S100 Ca 2+ -binding domain (aa 12-39). The differences between S100A15 and S100A7 concern those amino acids, which are thought to be important for the structure of the EF-hand domain (G for R at aa position 22, G for D at position 25) or in the Ca 2+ -binding (E for D at position 28). In contrast to S100A7, analysis of the amino acid sequence led to prediction of a Nterminal S100 Ca 2+ -binding domain (EF-hand) for the S100A15 (49) . Apart from the human S100A7, we found homology to the bovine Ca 2+ -binding protein in amniotic fluid 2 (bovine S100A7, gene bank acc. no.: D49550), with 84% identity as the next closest match (Fig. 4) . As for the human and bovine S100A7, the peptide sequence and the three amino acids gap in the nonconserved N-terminus of the S100A15 assign its position as a divergent member within the S100 family (34% identity to S100A11; 29% identity to S100A8).
Identification of an alternatively spliced isoform of the novel human S100
As mentioned before, Northern blot analysis showed an additional strong band (Fig. 2B) , when the ORF probe of the S100A15 was used for hybridization, indicating the existence of other small transcripts homologous to S100A15. The high homology between the S100A15 and the S100A7 gene suggested a similar genomic organization. Because a small transcript of 437 nt was descripted for the S100A7 (39), we assumed the existence of a small mRNA of similar size for the S100A15. The differences between the corresponding genomic sequences upstream of the coding regions permitted the synthesis of S100A15-specific primers for the PCR cloning, which led to the detection of a short transcript of 491 nt in length (S100A15-S) in psoriatic lesional skin. As shown for its long counterpart, the S100A15-S contains the same coding region (14-445 nt) but differs in length and composition of the untranslated regions (Fig. 3B , S100A15-S, acc.no.: AY189119). Northern blot analysis of RNA from psoriatic skin, using a specific probe for the short S100A15 mRNA, revealed a band at ~500 bp (Fig. 2C) , which was previously superimposed by the strong band representing mainly transcripts of S100A7 (Fig. 2B) .
Chromosomal localization and genomic organization of the alternatively spliced S100A15 isoforms
BLAST-alignment of the cDNA sequences to genomic libraries mapped S100A15 to chromosome 1q21, harboring a cluster of genes encoding for S100 proteins within the epidermal differentiation complex (EDC). We found that the orientation of the S100A15 is opposite to that of the flanking S100A7 and S100A8 genes, which reside ~40 kb up-and downstream of the S100A15 locus, respectively.
The S100A15 gene corresponds to a genomic region of 6702 nt in total (acc.no.: AL591704) and is organized in three exons and two introns (Fig. 4A) , with all exon/intron boundaries following the GT-AG rule (Fig. 4B) . Exon 1 is untranslated, exon 2 contains the translation initiation codon and encodes for the variant N-terminal Ca 2+ -binding domain, whereas exon 3 harbors the canonical Ca
2+
-binding motif at the C-terminus. Interestingly, the noncoding exon 1 is restricted to the long isoform, whereas for the short transcript, an additional sequence enlarging the 5′-UTR of exon 2 is found (Fig. 4A) . However, despite the differences in composition and length of their UTRs, both S100A15-isoforms share the same coding region. The genomic sequence and the mRNA sequences for both isoforms are available under GenBank acc.no. AY189117-AY189119.
Expression and distributional analysis of the alternatively spliced S100A15 isoforms
To determine the expression of the two alternatively spliced S100A15-transcripts in normal and psoriatic skin, we performed Northern blot and semiquantitative RT-PCR analysis for separate detection of the two S100A15 isoforms. Northern blot analysis revealed an increased hybridization for both S100A15 transcripts in nonlesional and lesional psoriatic skin compared with normal skin, with comparable expression levels between the individual samples (Fig. 5A) . These data were verified by semiquantitative-PCR, analyzing additional independent samples of normal and psoriatic skin, summarized in Figure 5B . In addition, we found that the two isoforms showed different expression levels in lesional skin, with an increase of >20-fold for the short S100A15 and >70-fold for the long isoform compared with healthy tissue, respectively.
Because psoriatic skin is characterized by morphological changes in both dermis and epidermis, we investigated the distribution of the S100A15-transcripts in normal and psoriatic skin. In situ hybridization, using a DIG-labeled antisense cRNA as a probe, indicated the expression of S100A15 transcripts restricted to the epidermis. In line with differential display RT-PCR analysis and Northern blot experiments, the results showed that elevated levels of S100A15 mRNAs are present in psoriatic epidermis as compared with its normal counterpart (Fig. 6 ).
Within the faint staining of healthy skin, a granular pattern was present in the basal epidermal layer (Fig. 6, arrows) , whereas the suprabasal layers of the epidermis appeared to be more strongly stained in lesional skin.
DISCUSSION
In the present study, we have cloned and characterized a novel member of the human S100 family based on differential display RT-PCR analysis, using RNA from normal and psoriatic skin. We used the advantage of the DDRT-PCR technique, which allows the identification of differentially regulated genes without preselection and independently of any existing gene sequence. DDRT-PCR has been shown to be a valuable research tool for the identification of gene products that might be involved in the pathogenesis of psoriasis and other diseases (50, 51) . However, the appearance of false positive results has been reported, requiring verification of expression by different techniques (52), for example, dot blot or Northern blot analysis. About 30-40% of the initial fragments stained by DDRT-PCR were shown to be truly positive in our confirmative analysis. Based on the strong differences in hybridization when comparing normal to lesional skin, we focused on clone 110 being the starting point for the detection of a novel psoriasis candidate gene, designated as S100A15.
Interestingly, the predicted S100A15 protein shares 93% overall identity with the S100A7. As expected for S100 protein motifs (48), the differences mainly concern the deduced N-terminal Ca 2+ -binding site (11% aa mismatch) and less the highly conserved Ca 2+ -binding EF hand motif localized at the C-Terminus (3% aa mismatch). Small differences, as between S100A15 and S100A7, involving structural and Ca -binding domain (53, 54) . This assumption is based on the results of the comparative analysis (49), which predicted an N-terminal S100-Ca 2+ -binding domain (EF-hand) for the S100A15 but not for the S100A7. However, the prediction for the S100A7 protein sequence is in agreement with structural analysis reporting a low Ca 2+ -binding capacity of the protein (55).
The calculated molecular weight of 11,305 Da for the S100A15 is in accordance with other S100 family members, such as for the S100A7 (11,326 Da) and the calgranulins (10,079-13,673 Da) (39, 56) . The introduction of basic and loss of acidic amino acids in the acidic C-Terminus of the S100A15 provide an explanation for the prediction of a basic isoelectrical point, which is rather atypical for S100 proteins (32) .
In addition, we found special features that refer mainly to the genomic organization of the S100A15 gene. In general, S100 genes code for a single transcript consisting of three exons and two introns, with the first exon being short and untranslated and the second and third encoding an EF-hand motif each (48) . For the S100A15, however, we detected two transcripts of ~0.5 and 4.4 kb in size resulting from the different noncoding regions. Alternative splicing has been reported only for the S100A4 so far, resulting in small transcripts of similar size (507 and 512 nt) (57) (58) (59) . In that case, the diversity of the S100A4-transcripts is defined by addition of a 5′-noncoding exon, whereas for the S100A15-transcripts the use of either a first noncoding exon (S100A15-L) or an extended first coding exon (S100A15-S) is shown (Fig. 4) . This latter feature seems to be similar to the pattern observed in a third S100A4-splice variant isolated from an invasive breast carcinoma, which has lost the noncoding exon 1, whereas the protein-coding exons 2 and 3 were present (59) .
In contrast to the S100A4-variants reported, additional diversity of the S100A15 is caused by the large 3′-UTR only present in the S100A15-L; this extended size is rather exceptional for members of the S100 family (60) . The organization of the S100A15-transcripts suggests that in addition to the 5′ alternative splicing, the use of two different polyadenylation signals may result in 3′-UTRs of different lengths (61, 62) . Alternative splicing is a versatile mechanism to create diversity and flexibility in the regulation of gene expression. For several genes, it was shown that the composition and length of the splice variants influence mRNA transcription, processing efficiency, and half-life (61) . It might be possible that one of these mechanisms is responsible for the different levels of the S100A15-spliced isoforms in psoriatic skin (Fig. 5) . Interestingly, several transcription factor binding sites were predicted in the 5′ upstream region of the S100A15; however, as for the related S100A7, no characteristic promotor region was found by computational analysis. Because several S100 genes are regulated coordinately, the presence of a common regulatory element, for example, enhancer or locus control region, can be assumed.
We found the expression of S100A15 beeing restricted to the basal proliferative cell layer of normal skin. This distribution is in line with the epidermal calcium gradient (63) , which controls the proliferation and differentiation of keratinocytes (64, 65) . In psoriatic skin, the altered epidermal calcium distribution might be responsible for the upregulation of the S100A15 in the upper epidermis, as has also be shown for other Ca 2+ -binding proteins (66, 67) . The expression of the S100A15 in proliferating keratinocytes of normal skin and hyperplastic psoriatic epidermis is indicative for the involvement of this protein in calcium-dependent proliferation processes. Furthermore, the increased S100A15 expression could be linked to psoriasis-associated inflammation or immune activation, as it has been reported for the related S100A7 and other S100 Ca
2+
-binding proteins (67) (68) (69) . Interestingly, the expression of S100A7 has shown to be associated with abnormal epidermal differentiation and tumor development (39, 40, 70, 71) . In contrast to the S100A7, the deduced amino acid sequence of the S100A15 is predicted to harbour a second Ca 2+ -binding site. Since the activity of S100 proteins is regulated by Ca 2+ -binding (31) , further studies have to show if S100A15 shows an altered state of activation or additional functions based on an enhanced Ca 2+ -binding capacity compared with the S100A7. Therefore, it will be of great interest to discriminate the expression of both genes in different diseases. Although the high homology between S100A15 and S100A7 might hinder the production of specific antibodies, individual gene expression could be analyzed on mRNA level as shown here.
Our study reports the discovery and characterization of the novel psoriasis-associated gene S100A15. Its unique genomic organization among the S100 family, leading to alternative splice variants promises further insight into the regulation of the S100 genes. The novel S100A15 gene, encoding for a protein with two Ca 2+ -binding EF-hand motifs, is likely to participate in the calcium homeostasis in the skin and might therefore be an important factor for proliferation and differentiation in psoriasis and other diseases. focusing on clone 110. Pooled RNA from normal skin, nonlesional, and lesional psoriatic skin was converted to cDNA and PCR amplified with anchored (5′-AAGCT 13 C-3′) and arbitrary #29 (5′-AAGCTTAGCAGCA -3′) primer. The radiolabelled products were separated on a denaturing 6% polyacrylamide gel and visualized by exposure to an X-ray film. The marked fragment showing increased expression in psoriatic skin was excised, reamplified, sequenced, and designated as clone 110. 2 . Northern blot analysis of S100A15 mRNA-isoforms. Pooled RNA (n=5) from lesional psoriatic skin was separated on a 2% denaturating agarose gel, and radiolabelled probes specific for the S100A15-L isoform (A), the S100 coding regions (B), and the S100A15-S isoform (C) were used for hybridization. human S100A15 with mammalian S100-proteins by similarity: human and bovine S100A7 (hS100A7 and bS100A7, respectively), rabbit and human S100A11 (rab S100A11 and hS100A11, respectively), and rat S100A9. Identical amino acid residues are indicated as black boxes, and similar amino acids are marked as grey boxes. The predicted Ca Individual total RNA samples from normal (4), nonlesional (3), and lesional (3) skin were hybridized with probes specific for the long and short isoform of the S100A15. Due to the homology to S100A7, probes were restricted to <250 nt in length to obtain isoform specific detection. B) Semiquantitative RT-PCR analysis: Comparative expression analysis of the short and the long S100A15 transcript in pooled samples (n=5) of normal, non-lesional, and lesional skin performed in two independent experiments. Note: Different RNA samples were used for Northern and semiquantitative RT-PCR analysis. *Significant differences (P<0.01) between indicated bars. 6 . In situ hybridization of S100A15 in normal and psoriatic skin. Detection of the short isoform of the S100A15 in normal and psoriatic lesional skin. In normal skin, the basal cell layer showing a granular staining is marked by arrows. Representative results from one of three independent experiments are shown (magnification: 100×).
